| scholarly article | Q13442814 |
| P50 | author | Oğuzhan Alagöz | Q56654355 |
| Ronald E Gangnon | Q56810665 | ||
| Amy Trentham-Dietz | Q88960210 | ||
| Donald L. Weaver | Q110141382 | ||
| Anna N. A. Tosteson | Q110143968 | ||
| P2093 | author name string | John M Hampton | |
| Kim Dittus | |||
| Elizabeth S Burnside | |||
| Brian L Sprague | |||
| Pamela M Vacek | |||
| Natasha K Stout | |||
| Ted A James | |||
| Mehmet Ali Ergun | |||
| Sally D Herschorn | |||
| P2860 | cites work | The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model | Q27347267 |
| Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography. | Q33792616 | ||
| Prevalence of breast carcinoma in situ in the United States | Q33908894 | ||
| The benefits and harms of breast cancer screening: an independent review | Q34309421 | ||
| Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality | Q34736052 | ||
| Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts | Q35039764 | ||
| Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts. | Q35683407 | ||
| Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials | Q35740423 | ||
| Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision | Q35808405 | ||
| A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone | Q35816292 | ||
| Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status | Q36277707 | ||
| Additional common inputs for analyzing impact of adjuvant therapy and mammography on U.S. mortality | Q36619874 | ||
| Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis | Q36724704 | ||
| Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers | Q36738628 | ||
| A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast | Q36843620 | ||
| Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening | Q37070417 | ||
| Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies | Q37364628 | ||
| Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes | Q37444608 | ||
| Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study | Q37561281 | ||
| Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions | Q37653428 | ||
| Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery | Q38125030 | ||
| Emerging trends in surgical and adjuvant radiation therapies among women diagnosed with ductal carcinoma in situ | Q38407639 | ||
| Cancer Statistics, 2017. | Q39038674 | ||
| Risk prediction for local versus regional/metastatic tumors after initial ductal carcinoma in situ diagnosis treated by lumpectomy. | Q40768655 | ||
| The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score™ result | Q40882141 | ||
| Risk of recurrence of ductal carcinoma in situ by oncotype Dx technology: some concerns | Q44991699 | ||
| Addressing overtreatment of screen detected DCIS; the LORIS trial | Q47385333 | ||
| Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening | Q47727227 | ||
| Cost-effectiveness of contralateral prophylactic mastectomy for prevention of contralateral breast cancer | Q48082941 | ||
| Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. | Q51914599 | ||
| Estimating Breast Cancer Survival by Molecular Subtype in the Absence of Screening and Adjuvant Treatment. | Q52350449 | ||
| The University of Wisconsin Breast Cancer Epidemiology Simulation Model: An Update. | Q52648598 | ||
| Validation and use of a mathematical model to estimate the benefits of screening younger women for breast cancer. | Q52743761 | ||
| Retrospective cost-effectiveness analysis of screening mammography. | Q53241570 | ||
| Cost of care for elderly cancer patients in the United States. | Q53730492 | ||
| Modeling the dissemination of mammography in the United States | Q56940783 | ||
| Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling | Q64461485 | ||
| Contribution of Breast Cancer to Overall Mortality for US Women | Q64461488 | ||
| Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors | Q68009563 | ||
| Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999 | Q79220367 | ||
| Competing risks to breast cancer mortality | Q79220370 | ||
| The Wisconsin Breast Cancer Epidemiology Simulation Model | Q79220380 | ||
| Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the cisnet breast cancer base case analysis | Q79220390 | ||
| Breast cancer risk factors and second primary malignancies among women with breast cancer | Q79448806 | ||
| Characterizing the impact of 25 years of DCIS treatment | Q83577093 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 229-239 | |
| P577 | publication date | 2017-11-28 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening | |
| P478 | volume | 168 |
| Q94596766 | Evaluation of ductal carcinoma in situ grade via triple-modal molecular imaging of B7-H3 expression | cites work | P2860 |
Search more.